Neuberger Berman Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Neuberger Berman Group's KRYS Position: Q3 2026 in Review
Neuberger Berman Group reduced its Krystal Biotech (KRYS) stake by 5.9% in Q3 2026, selling an estimated $1.05M and leaving 48,841 shares worth $16.2M. The position accounts for 0.01% of the portfolio, ranked #736.
Neuberger Berman Group first reported a position in KRYS in Q1 2019 and has held it in 15 quarters since. The position peaked at $19.3M in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Neuberger Berman Group held 48,841 shares of Krystal Biotech worth $16.2M as of Q3 2026.
- Neuberger Berman Group sold 3,035 Krystal Biotech shares in Q3 2026, an estimated $1.05M.
- Krystal Biotech made up 0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #736 holding.
- Neuberger Berman Group first reported a position in Krystal Biotech in Q1 2019 and has held it in 15 quarters since.
- Neuberger Berman Group's Krystal Biotech position peaked at $19.3M in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.